Themis Medicare Share Price

Themis Medicare

CMP as on 10-Aug-20 15:06

₹ 396.55
3.10 0.79%

Open

₹ 395.60

Turnover (lac)

₹ 70

Prev. Close

₹ 393.45

Day's Vol (shares)

₹ 17,562

Day's Range (₹)

₹ 395.00
₹ 421.00

CMP as on10-Aug-20 14:12

₹ 400.00
8.8 2.25%

Open

₹ 410.00

Turnover (lac)

Prev. Close

₹ 391.20

Day's Vol (shares)

₹ 439

Day's Range

₹ 396.70
₹ 424.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-Jun-2020 - -
THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/06/2020 ,inter alia, to consider and approve 1. To consider the Audited Financial Results for the Quarter/Year ended on 31st March, 2020. 2. To consider recommending Dividend if any on the equity shares of the Company for the financial year 2019-20, Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2020, inter alia, has recommended dividend for Financial Year ended March 31, 2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs. 10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. The Board of Directors at its meeting held today, considered and approved the following matters: 1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2020. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2020 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs.10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM 3. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2020-21. 4. Appointed Mr. Shirish Shetye of M/s. Shirish Shetye & Associates, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 50thAnnual General Meeting. (As Per BSE Announcement Dated on 08.06.2020)
Board Meeting - 21-Jan-2020 - -
Pursuant to the captioned subject, we wish to inform you the following: 1. The meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Friday, 7th February, 2020 inter alia, to consider the Un-audited Standalone and Consolidated Financial Results for the Quarter and nine months ended on 31st December, 2019. 2. Pursuant to notification issued by Ministry of Road Transport and Highways, Government of India, making it mandatory to include Feracrylum 1% Gel 15gms in first aid kit for all types of vehicles coming out from the Auto Manufacturers, the Company has started receiving orders for supply of Feracrylum 1% Gel 15gms to be included in first aid kit and is likely to receive similar such orders in future. 3. The Company is presently negotiating with various parties for utilising spare capacity for carrying out contract manufacturing of finished products, and if negotiations are successful, the Company will enter into contracts with such parties. THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results for the Quarter/ Nine months ended on 31st December, 2019. (As Per BSE Announcement dated on 27/01/2020) 1.Approved the Unaudited Standalone and Consolidated financial results for the Quarter and Nine Months ended 31st December, 2019. 2.Alloted 7050 Equity Shares to eligible employees pursuant to exercise of ESOP Options under Themis ESOS Scheme 2012. 3.Approved proposal to seek consent of members under Section 188 of the Companies Act, 2013 for proposed Related Party Transaction. 4.Approved Draft Notice of Postal Ballot for seeking consent of members under Section 188 of the Companies Act, 2013 for proposed Related Party Transaction 5.Appointed M/s. Shirish Shetye and Associates as scrutinizer for the purpose of conducting postal ballot. 6.Appointed M/s. Shirish Shetye and Associates as Secretarial Auditor for the financial year 2019-20 for the purpose of conducting Secretarial Audit. This may be taken as compliance under the Listing Regulations. (As Per BSE Announcement Dated on 07/02/2020) Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of advertisement published in newspaper(s) viz. the Indian Express (English) and Financial Express (Gujarati) newspaper dated 8th February, 2020 for the Standalone and Consolidated Financial Results for the Quarter and Nine Months ended December 31, 2019. Kindly take the same on record (As Per BSE Announcement Dated 12.02.2020)
Board Meeting - 05-Nov-2019 - -
THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Un-audited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2019. The Board of Directors at its meeting held today, considered and approved the following matters 1. Approved the Unaudited Standalone and Consolidated financial results for the Quarter and Half Year ended 30th September, 2019. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September, 2019 is enclosed herewith. 2. Re-constituted the Nomination and Remuneration Committee of the Board of Directors of the Company pursuant to Section 178 of the Companies Act and Regulation 19 of the SEBI (LODR) Regulations, 2015. The revised composition of the Nomination and Remuneration Committee is as under: Mr. Vijay Agarwal Chairman of the Committee Mr. Humayun Dhanrajgir Member of the Committee Mr. H. Subramaniam Member of the Committee Mr. Rajneesh Anand Member of the Committee This may be taken as compliance under the Listing Regulations. (As Per BSE Announcement Dated on 14/11/2019)